Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 1, 2009, Pages 84-87

  Kurian, K M ^a,c   Forbes, R B ^b   Colville, S ^a   Swingler, R J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b CRAIGAVON AREA HOSPITAL   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASPIRATION PNEUMONIA; AUTOPSY; BRONCHOPNEUMONIA; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DEGENERATIVE DISEASE; EPISTAXIS; FEMALE; HEART TAMPONADE; HUMAN; LUNG EDEMA; MALE; MOTOR NEURON DISEASE; NEOPLASM; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEPSIS; BRAIN DISEASE; COHORT ANALYSIS; HEART DISEASE; MIDDLE AGED; MORTALITY; PATHOLOGY; REGISTER; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; AUTOPSY; BRAIN DISEASES; BRONCHOPNEUMONIA; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RESPIRATORY INSUFFICIENCY; SCOTLAND; YOUNG ADULT;

EID: 58249089856     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.149708     Document Type: Article

References (21)

1. Nirmalananthan N, Greensmith L. Amyotrophic lateral sclerosis: recent advances and future therapies. Curr Opin Neurol 2005; 18:712-19.
2. Davenport RJ, Swingler RJ. Chancellor AM, et al. Avoiding false positive diagnoses of motor neurone disease: lessons from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 1996; 60:147-51.
3. Traynor BJ, Codd MB, Corr B, et al. Amyotrophic lateral sclerosis mimic syndromes: a population-based study. Arch Neurol 2000; 57:109-13.
4. Parboosingh JS, Figlewicz DA, Krizus A, et al. Spinobulbar muscular atrophy can mimic ALS: the importance of genetic testing in male patients with atypical ALS. Neurology 1997; 49:568-72.
5. Chaudhuri K. Crump S, Al-Sarraj, et al. The validation of the El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1995; 129(Suppl) 11-12.
6. Chancellor A, Swingler RJ, Fraser H, et al, for the Scottish Motor Neurone Disease Research Group. The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry 1992; 55:536-41.
7. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neurone Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994; 124(Suppl):96-107.
8. Traynor BJ, Codd MB, Corr B, et al. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study. Arch Neurol 2000; 57:1171-6.
9. Forbes RB, Colville S, Cran GW, et al. Unexpected decline in survival from amyotrophic lateral sclerosis/motor neuron disease. J Neurol Neurosurg Psychiatry 2004; 75:1753-5.
10. Colosimo C, Hughes AJ, Kilford L, et al. Lewy body cortical involvement may not always predict dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2003; 74:852-6.
11. Nath U, Thompson R, Wood R, et al. Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neurol Neurosurg Psychiatry 2005; 76:498-502.
12. Victoroff J, Mack WJ, Lyness SA, et al. Multicenter clinicopathological correlation in dementia. Am J Psychiatry 1995; 152:1476-84.
13. Wenning GK, Ben-Shlomo Y, Hughes A, et al. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 2000; 68:434-40.
14. Hamilton RL, Bowser R. Alzheimer disease pathology in amyotrophic lateral sclerosis. Acta Neumpathol (Berl) 2004; 107:515-22.
15. Josephs KA, Parisi JE, Dickson DW. Alpha-synuclein immunohistochemistry in 2 cases of co-occcuring idiopathic Parkinson's disease and motor neurone disease. Mov Disord 2005; 20:1515-20.
16. Liang TW, Forman MS, Duda JE, et al. Multiple pathologies in a patient with a progressive neurodegenerative syndrome. JNNP 2005; 76:252-5.
17. Josephs KA, Parisi JE, Knopman DS, et al. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. Arch Neurol 2006; 63:506-12.
18. Kersaitis C, Halliday GM, Xuereb JH, et al. Ubiquitin-positive inclusions and progression of pathology in frontotemporal dementia and motor neuron disease identifies a group with mainly early pathology. Neuropathol Appl Neurobiol 2006; 32:83-91.
19. Neumann M, Sampathi DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and ALS. Science 2006; 314:130-3.
20. Mizuno Y, Amari M, Takatana M, et al. Immunoreactivities of p62, an ubiquitinbinding protein in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J Neurol Sci 2006; 249:13-18.
21. Chou S. Motorneurone inclusions in ALS are heavily ubiquitinated. J Neumpathol Exp Neurol 1988; 47:334.